世界のリドカイン注射市場予測（～2028年）：0.005、 0.01、 0.015、 0.02

• 英文タイトル：Global Lidocaine Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8876 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

リドカイン注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のリドカイン注射の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 リドカイン注射市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・0.005、 0.01、 0.015、 0.02 用途別セグメントは次のように区分されます。 ・病院、クリニック、リカバリーセンター 世界のリドカイン注射市場の主要な市場プレーヤーは以下のとおりです。 ・Fresenius Kabi、Hikma、Pfizer、Amphastar、AuroMedics、Livealth Biopharma、Hameln Pharmaceuticals、AdvaCare Pharma、Actiza Pharmaceutical、JumpCan、LongerPharm Group、Hainan Tianhuang Pharmacy、Yabao Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、リドカイン注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なリドカイン注射メーカーの企業概要、2019年～2022年までのリドカイン注射の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なリドカイン注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別リドカイン注射の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのリドカイン注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのリドカイン注射市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびリドカイン注射の産業チェーンを掲載しています。 ・第13、14、15章では、リドカイン注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Fresenius Kabi、Hikma、Pfizer、Amphastar、AuroMedics、Livealth Biopharma、Hameln Pharmaceuticals、AdvaCare Pharma、Actiza Pharmaceutical、JumpCan、LongerPharm Group、Hainan Tianhuang Pharmacy、Yabao Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：0.005、 0.01、 0.015、 0.02 ・用途別分析2017年-2028年：病院、クリニック、リカバリーセンター ・リドカイン注射の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・リドカイン注射のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・リドカイン注射のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・リドカイン注射の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・リドカイン注射の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Lidocaine Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lidocaine Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Lidocaine Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 0.005 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lidocaine Injection include Fresenius Kabi, Hikma, Pfizer, Amphastar, and AuroMedics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lidocaine Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
0.005
0.01
0.015
0.02
Market segment by Application can be divided into
Hospital
Clinic
Recovery Center
The key market players for global Lidocaine Injection market are listed below:
Fresenius Kabi
Hikma
Pfizer
Amphastar
AuroMedics
Livealth Biopharma
Hameln Pharmaceuticals
AdvaCare Pharma
Actiza Pharmaceutical
JumpCan
LongerPharm Group
Hainan Tianhuang Pharmacy
Yabao Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lidocaine Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lidocaine Injection, with price, sales, revenue and global market share of Lidocaine Injection from 2019 to 2022.
Chapter 3, the Lidocaine Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lidocaine Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lidocaine Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lidocaine Injection.
Chapter 13, 14, and 15, to describe Lidocaine Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Lidocaine Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lidocaine Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 0.005
1.2.3 0.01
1.2.4 0.015
1.2.5 0.02
1.3 Market Analysis by Application
1.3.1 Overview: Global Lidocaine Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Recovery Center
1.4 Global Lidocaine Injection Market Size & Forecast
1.4.1 Global Lidocaine Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lidocaine Injection Sales in Volume (2017-2028)
1.4.3 Global Lidocaine Injection Price (2017-2028)
1.5 Global Lidocaine Injection Production Capacity Analysis
1.5.1 Global Lidocaine Injection Total Production Capacity (2017-2028)
1.5.2 Global Lidocaine Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lidocaine Injection Market Drivers
1.6.2 Lidocaine Injection Market Restraints
1.6.3 Lidocaine Injection Trends Analysis
2 Manufacturers Profiles
2.1 Fresenius Kabi
2.1.1 Fresenius Kabi Details
2.1.2 Fresenius Kabi Major Business
2.1.3 Fresenius Kabi Lidocaine Injection Product and Services
2.1.4 Fresenius Kabi Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hikma
2.2.1 Hikma Details
2.2.2 Hikma Major Business
2.2.3 Hikma Lidocaine Injection Product and Services
2.2.4 Hikma Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Lidocaine Injection Product and Services
2.3.4 Pfizer Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Amphastar
2.4.1 Amphastar Details
2.4.2 Amphastar Major Business
2.4.3 Amphastar Lidocaine Injection Product and Services
2.4.4 Amphastar Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AuroMedics
2.5.1 AuroMedics Details
2.5.2 AuroMedics Major Business
2.5.3 AuroMedics Lidocaine Injection Product and Services
2.5.4 AuroMedics Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Livealth Biopharma
2.6.1 Livealth Biopharma Details
2.6.2 Livealth Biopharma Major Business
2.6.3 Livealth Biopharma Lidocaine Injection Product and Services
2.6.4 Livealth Biopharma Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hameln Pharmaceuticals
2.7.1 Hameln Pharmaceuticals Details
2.7.2 Hameln Pharmaceuticals Major Business
2.7.3 Hameln Pharmaceuticals Lidocaine Injection Product and Services
2.7.4 Hameln Pharmaceuticals Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AdvaCare Pharma
2.8.1 AdvaCare Pharma Details
2.8.2 AdvaCare Pharma Major Business
2.8.3 AdvaCare Pharma Lidocaine Injection Product and Services
2.8.4 AdvaCare Pharma Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Actiza Pharmaceutical
2.9.1 Actiza Pharmaceutical Details
2.9.2 Actiza Pharmaceutical Major Business
2.9.3 Actiza Pharmaceutical Lidocaine Injection Product and Services
2.9.4 Actiza Pharmaceutical Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 JumpCan
2.10.1 JumpCan Details
2.10.2 JumpCan Major Business
2.10.3 JumpCan Lidocaine Injection Product and Services
2.10.4 JumpCan Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 LongerPharm Group
2.11.1 LongerPharm Group Details
2.11.2 LongerPharm Group Major Business
2.11.3 LongerPharm Group Lidocaine Injection Product and Services
2.11.4 LongerPharm Group Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Hainan Tianhuang Pharmacy
2.12.1 Hainan Tianhuang Pharmacy Details
2.12.2 Hainan Tianhuang Pharmacy Major Business
2.12.3 Hainan Tianhuang Pharmacy Lidocaine Injection Product and Services
2.12.4 Hainan Tianhuang Pharmacy Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Yabao Pharmaceutical
2.13.1 Yabao Pharmaceutical Details
2.13.2 Yabao Pharmaceutical Major Business
2.13.3 Yabao Pharmaceutical Lidocaine Injection Product and Services
2.13.4 Yabao Pharmaceutical Lidocaine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lidocaine Injection Breakdown Data by Manufacturer
3.1 Global Lidocaine Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lidocaine Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lidocaine Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Lidocaine Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Lidocaine Injection Manufacturer Market Share in 2021
3.5 Global Lidocaine Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lidocaine Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lidocaine Injection Market Size by Region
4.1.1 Global Lidocaine Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Lidocaine Injection Revenue by Region (2017-2028)
4.2 North America Lidocaine Injection Revenue (2017-2028)
4.3 Europe Lidocaine Injection Revenue (2017-2028)
4.4 Asia-Pacific Lidocaine Injection Revenue (2017-2028)
4.5 South America Lidocaine Injection Revenue (2017-2028)
4.6 Middle East and Africa Lidocaine Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lidocaine Injection Sales in Volume by Type (2017-2028)
5.2 Global Lidocaine Injection Revenue by Type (2017-2028)
5.3 Global Lidocaine Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lidocaine Injection Sales in Volume by Application (2017-2028)
6.2 Global Lidocaine Injection Revenue by Application (2017-2028)
6.3 Global Lidocaine Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lidocaine Injection Sales by Type (2017-2028)
7.2 North America Lidocaine Injection Sales by Application (2017-2028)
7.3 North America Lidocaine Injection Market Size by Country
7.3.1 North America Lidocaine Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Lidocaine Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lidocaine Injection Sales by Type (2017-2028)
8.2 Europe Lidocaine Injection Sales by Application (2017-2028)
8.3 Europe Lidocaine Injection Market Size by Country
8.3.1 Europe Lidocaine Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Lidocaine Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lidocaine Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Lidocaine Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Lidocaine Injection Market Size by Region
9.3.1 Asia-Pacific Lidocaine Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lidocaine Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lidocaine Injection Sales by Type (2017-2028)
10.2 South America Lidocaine Injection Sales by Application (2017-2028)
10.3 South America Lidocaine Injection Market Size by Country
10.3.1 South America Lidocaine Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Lidocaine Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lidocaine Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Lidocaine Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Lidocaine Injection Market Size by Country
11.3.1 Middle East & Africa Lidocaine Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lidocaine Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lidocaine Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lidocaine Injection
12.3 Lidocaine Injection Production Process
12.4 Lidocaine Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lidocaine Injection Typical Distributors
13.3 Lidocaine Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---